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Abstract
Background: Functional gastrointestinal disorders (FGID) are defined by a combination of chronic or recurrent
gastrointestinal symptoms. Prevalence rates of FGID are high. Symptoms are associated with distress, and sufferers
show high stress levels. However, the current diagnostic criteria do not consider subjective distress elicited by the
symptoms, thus potentially leading to overestimated prevalence rates. The aim of this study was to explore the
reduction in prevalence rates when distress is considered in the diagnostic criteria.
Methods: In this web-based study, FGID were diagnosed using the Rome II criteria. Prevalence rates with and
without subjective distress elicited by the symptoms were computed. Additionally, stress levels and stress reactivity
were assessed.
Results: Prevalence rates of FGID in our sample were similar to those in other studies. However, when considering
the distress criterion, on average, a decrease of 38.51% was found in the prevalence rates of FGID. Sufferers who
were subjectively distressed by their symptoms reported significantly higher stress levels than non-distressed
subjects (all p < 0.001).
Conclusions: The consideration of a criterion of subjective distress in the diagnosis of FGID has consequences for
actual prevalence rates of FGID. Distressed subjects differ markedly from non-distressed subjects in terms of their
stress levels. The inclusion of a distress criterion in the ongoing development of diagnostic criteria for FGID is
therefore warranted.
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Background
Functional gastrointestinal disorders (FGID) are defined
by variable combinations of chronic or recurrent gastro-
intestinal symptoms that cannot be explained by structural
or biochemical abnormalities [1]. In general, prevalence
rates of FGID are high, ranging from 35% to 70% [1,2],
with a considerable overlap between different syndromes
[1]. A female preponderance has been found for most
FGID [1,3,4]. Besides the exclusion of organic diseases by
means of medical examination, the use of the Rome cri-
teria is recommended to confirm an FGID diagnosis. Up-
dated versions of the original Rome criteria of 1994 [5]
were published in 1999 (Rome II [6]) and in 2006 (Rome
III [7]). The prevalence rates of FGID depend on various
sample characteristics such as sex, ethnicity, socio-
economic status, and lifestyle factors [1,2]. Moreover,
prevalence rates vary depending on the diagnostic cri-
teria used, with the current Rome III criteria being less
restrictive than the Rome II criteria with respect to symp-
tom duration [8,9]: Whereas the Rome II criteria include a
symptom duration of 12 months, the Rome III criteria
take into account a 6-month duration. There is stronger
evidence for the validity of the Rome II criteria [10], which
are more frequently used in clinical research [11].
To date, the pathophysiology of FGID remains elusive,
and treatment options are limited. Current knowledge
suggests that FGID etiologies are biopsychosocial in na-
ture. Given that psychological factors play a significant
role in FGID, it is interesting to note that these are not
considered in the diagnosis of FGID. In essence, diagno-
sis is reached by summarizing specific symptoms that
have been present for a certain amount of time and for* Correspondence: nater@uni-marburg.de1Department of Psychology, University of Marburg, Gutenbergstrasse
18,35037, Marburg, Germany
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which there is no medical explanation. Importantly, how-
ever, FGID cause distress in patients struck by the illness,
with some patients suffering more than others.
An important question therefore refers to how distress
is defined. A great number of studies quantified the level
of subjective distress using measures of quality of life.
However, in all of these studies, distress was defined as
psychological distress related to anxiety and depression.
The lack of a uniform application of a distress measure
in FGID is particularly striking for researchers and practi-
tioners in the field of psychiatry, as it is a well-established
standard in psychiatric diagnostic criteria using the Diag-
nostic and Statistical Manual of Mental Disorders (DSM-
IV). For the diagnosis of psychiatric disorders according
to the DSM-IV, clinical significance is only given if a pa-
tient reports being subjectively distressed by his or her
symptoms. As yet, the impact of subjective distress elicited
by the symptoms on the prevalence rates of FGID has not
been investigated, even though such a consideration might
have clinically relevant consequences.
Diagnoses made according to the Rome II criteria or
the current Rome III criteria do not consider subjective
distress elicited by the symptoms. It seems important,
however, to only diagnose those individuals with FGID
who are actually suffering from their symptoms. In stud-
ies investigating one particular FGID, i.e. irritable bowel
syndrome (IBS), no statistically significant differences were
found between persons who were seeking medical advice
and persons who were not seeking medical advice with re-
gard to the number or severity of complaints, despite the
fact that all individuals fulfilled the full criteria for IBS
[12,13]. This implies that some persons do not seem to be
sufficiently bothered by the number and severity of their
gastrointestinal symptoms to seek medical advice. It may
therefore be questioned whether their “illness” is actually
clinically relevant if they do not feel the need to do some-
thing about it. Despite this, persons who do not find their
symptoms bothersome are also included in epidemio-
logical studies of FGID prevalence rates. Accordingly, the
findings from population-based studies cannot be general-
ized to persons seeking medical care.
As noted above, psychological factors have been identi-
fied as playing an important role in FGID, with stress be-
ing assumed to play a central role in its development [14].
We describe subjective stress in accordance with Lazarus
et al., who stated that stress is not defined by the objective
requirements of the situation, but by the person’s subject-
ive evaluation of the situation and his/her strategies to cope
with it [15]. If a person perceives situations as stressful over
a longer period of time, subjective stress may result in
chronic stress. According to the allostatic load model [16],
chronic stress may ultimately lead to wear and tear on the
body, with the consequence of stress-related conditions
such as FGID or certain psychiatric disorders. With regard
to FGID, studies found that the amount of events a person
perceives as stressful is linked to the presence of gastro-
intestinal symptoms [17,18]. Moreover, subjects with FGID
report more negative life events as well as fewer positive
life events [18-20]. These findings highlight the importance
of perceived stress in FGID.
Chronic stress is often mentioned together with anx-
iety and depression traits, but the terms should not be
used interchangeably. Anxiety and depression can be
defined as psychopathological phenomena, which show
common characteristics with chronic stress (e.g. negative
affectivity, dysregulation of stress hormones).
Moreover, in laboratory studies, it was found that
persons with FGID show a greater psychological and
biological reactivity to stressors, which might influence
the perception of gastrointestinal discomfort and pain
[21-23]. A previous online study, which examined both
chronic stress and stress reactivity, found that even young
subjects with FGID report higher levels of chronic stress
and stress reactivity compared to controls [24]. In sum,
these studies show that people with FGID have different
stress experiences and react differently to stressors com-
pared to healthy controls.
Therefore, examining potential differences in stress
levels between individuals who are distressed by their
symptoms and those who are not would appear to be of
importance. It is hypothesized that being distressed by
one’s symptoms may play a critical role in whether or
not one receives a clinically meaningful diagnosis of FGID.
The aim of our study was twofold: 1) We investigated
potential differences in prevalence rates between people
fulfilling the Rome II criteria for FGID and people fulfill-
ing both the Rome II criteria and a subjective distress cri-
terion, and 2) we examined differences in chronic stress
and stress reactivity between these groups and compared
both to a healthy control group. We decided to test our
hypothesis in a relatively homogenous group of young in-
dividuals. Should we find that the inclusion of a distress
criterion has an impact on FGID prevalence rates in this
population, the necessity of this approach could be tested
in a clinical sample of patients.
Methods
Participants and procedure
Data were collected in 2004 in the German-speaking part
of Switzerland. All potential participants from two univer-
sities (University of Zurich and Federal Institute of Tech-
nology Zurich) were contacted via e-mail and asked to
take part in a survey on stress and bodily symptoms. Par-
ticipation was voluntary and all subjects provided elec-
tronic informed consent. Anonymity was guaranteed by
automatically sending a username, a password and an
internet link to the survey to the participants. Further psy-
chometric data and subjects’ characteristics were saved
Markert et al. BMC Gastroenterology  (2014) 14:215 Page 2 of 7
separately. In the case of acute psychological problems,
clinic contact information was provided. All procedures
were in accordance with the ethical standards laid down
in the 1964 Declaration of Helsinki, and the web survey
study design was approved by the ethics committee of the
Canton of Zurich. Written informed consent was obtained
from all participants.
The complete online survey consisted of 178 items.
Participants had to answer all of the questions on each
page of the survey in order to continue to the next page.
This enabled complete datasets to be collected. As com-
pensation for their effort, participants had a chance to
win cinema tickets and a dining coupon. The study was
carried out under conditions in accordance with the
Declaration of Helsinki.
Measurements
In the first part of the online survey, sociodemographic and
health-related data (e.g. diseases, medication, consultation
rates, use of addictive drugs) were collected. A dichotom-
ous question was used to assess whether participants regu-
larly visited the doctor (“regular doctor visits”: “yes/no”). If
organic diseases were reported which were potentially re-
lated to gastrointestinal symptoms, participants were ex-
cluded from the calculation of prevalence rates.
Subsequently, the following questionnaires about FGID
(including an assessment of subjective distress) and stress
were applied:
The Gastro-Questionnaire [25], which allows the
assessment of 27 gastrointestinal symptoms, was
administered to analyze the prevalence of twenty FGID
(Additional file 1: Table S1) according to the Rome II
criteria [6]. The occurrence of each symptom was rated
on a 4-point scale: 0 (not at all), 1 (from time to time),
2 (frequently), and 3 (nearly always). The level of
subjective distress for each symptom was rated on a
5-point scale from 0 (no distress) to 4 (very severe
distress). Persons who fulfilled the Rome II criteria for
an FGID and graded the distress for one symptom of
this disorder with values of 2 or higher were classified
as “distressed subjects”.
The Trier Inventory for the Assessment of Chronic Stress
(TICS) [26] was included to gather information about
subjectively perceived stress within the last 12 months.
This self-report questionnaire consists of 57 items
concerning eight types of chronic stress (work overload,
social work overload, overextended at work, lack of
social recognition, work discontent, social tension,
pressure to succeed, social isolation).
The Stress Reactivity Scale (SRS) [27,28] is an
instrument which measures reactivity to potentially
stressful situations. A three-level response format is
specified for each of the 36 items. In addition to general
stress reactivity, the scale also assesses stress reactivity
in specific domains (Reactivity to Work Overload,
Reactivity to Social Conflicts, Reactivity to Social Stress,
Reactivity to Failure, Anticipatory Reactivity, Prolonged
Reactivity).
Statistical analysis
Prevalence rates of FGID with and without distress accord-
ing to the Rome II criteria were calculated in percentages.
Before univariate analyses of variance were computed, data
were tested for normal distribution using the Kolmogorov-
Smirnov test and by calculating skewness and kurtosis of
the distribution. A significant deviation from normal distri-
bution is assumed if values for skewness are | ≤ 2| and
values for kurtosis are | ≥ 7| [29]. According to the defin-
ition by West et al. [29], normal distribution was assumed
for these data. Additionally, data were tested for homogen-
eity of variance using the Levene’s test. Homogeneity of
variance was violated in some cases, leading to more con-
servative results, with the exception of the scale “stress
reactivity before stressors”, which showed a more liberal
result. Subsequently, univariate analyses of variance were
calculated for the comparison of scale means. For statistical
analysis, SPSS version 20 was used.
Results
Sample characteristics
In total, 1901 participants completed the web survey.
Forty-four (2.31%) participants had to be excluded from
the calculations because they reported an organic disease
which might have explained their gastrointestinal symp-
toms. Thus, a total of 1857 participants were included in
the analysis. One thousand and sixty-eight (57.50%) were
women and 789 (42.50%) were men, and the mean age
was 23.9 years (SD = 3.96). As all participants were uni-
versity students, they were comparable with regard to
their level of education.
Prevalence rates of FGID
Additional file 1: Table S1 shows prevalence rates of FGID
diagnoses according to the Rome II criteria alone com-
pared to prevalence rates of FGID diagnoses with add-
itional consideration of being distressed by the symptoms.
Prevalence rates of FGID diagnoses according to the
Rome II criteria without consideration of subjective dis-
tress were also reported in Suarez, Herdener-Pinnekamp,
Ehlert, and Nater (under review). 1166 (62.79%) fulfilled
the Rome II criteria for at least one diagnosis. The number
of diagnoses ranged from one to six, with 548 (29.51%)
persons reporting only one FGID, 379 (20.41%) reporting
two, 157 (8.45%) reporting three, 62 (3.34%) reporting
four, 18 (0.97%) reporting five, and two persons (0.11%)
reporting six FGID diagnoses occurring concomitantly.
When the distress criterion was taken into account, the
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prevalence rates changed as follows: 717 participants
(38.61%) fulfilled the Rome criteria for at least one diag-
nosis. The number of diagnoses ranged from one to six
FGID, with 399 (21.5%) persons reporting only one
FGID, 196 (10.55%) reporting two, 78 (4.20%) reporting
three, 34 (1.83%) reporting four, 9 (0.48%) reporting five
and one person (0.05%) reporting six FGID diagnoses
occurring concomitantly.
Thus, on average, a 38.51% decrease in prevalence
rates was observed across all FGID diagnoses and all
participants when subjective distress elicited by the symp-
toms was additionally considered. The largest differences
were found for functional diarrhea (100% lower preva-
lence rate), aerophagia (77.08%), chronic functional ab-
dominal pain (68.99%), and functional abdominal bloating
(61.13%). No changes or only small reductions in the
prevalence rates were found for proctalgia fugax (0%),
functional incontinence (1.52%), and functional constipa-
tion (2.5%). Those changes were more distinct in men
than in women (lower prevalence rates in 13 of the 21
syndromes in men compared to lower prevalence rates in
6 of the 21 syndromes in women and identical prevalence
rates in 2 of the 21 syndromes).
There were 691 participants who did not fulfill any
FGID diagnosis (healthy control group, HCG). In the next
step, participants who fulfilled at least one diagnosis ac-
cording to the Rome II criteria (n = 1166) were divided
into a distressed (n = 717) and a non-distressed (n = 449)
subgroup (see above). A group comparison indicated that
there was a higher proportion of women in the distressed
subgroup (66.10%) than in the non-distressed subgroup
(56.1%) and the HCG (49.50%) (χ2 (2, n = 1068) = 70.05,
p < .001). No significant differences were observed with re-
gard to age (distressed subgroup: mean age = 23.88 years;
non-distressed subgroup: mean age = 23.89 years; HCG:
mean age = 23.86 years; F = .007; p = 0.993).
The three groups differed regarding clinical variables.
The distressed subgroup reported significantly more symp-
toms than the non-distressed subgroup and the HCG
(distressed subgroup: mean value of symptoms = 4.77; non-
distressed subgroup: mean value of symptoms = 2.86; HCG:
mean value of symptoms = 0.51; F = 557.86; p < 0.001). In
the distressed subgroup, there were more persons under-
taking regular doctor visits (23.80%) as compared to the
non-distressed subgroup (18.90%) and the HCG (13.50%)
(χ2 (2, n = 349) = 38.81, p < .001). Less than one third
(29.93%) of all participants with at least one FGID diag-
nosis visited the doctor regularly.
Significant differences between the three subgroups
were also observed with respect to chronic stress and
stress reactivity (Additional file 2: Table S2) for all sub-
scales of the TICS and the SRS, with the highest values
in all subscales for the distressed group, followed by the
non-distressed group and the HCG. Analyses separated
by gender led to comparable results for men and women,
with the exception that men showed slightly different
means in two TICS scales (Social Tension: F = 4.36, p <
0.05; SRS, Reactivity to Social Conflicts: F = 3.91, p < 0.05).
Discussion
The purpose of this study was to determine changes in
prevalence rates of FGID in a non-clinical sample when
subjective distress elicited by the symptoms is taken into
account. Moreover, it was of interest to ascertain whether
the subjects with FGID diagnoses and subjective distress
exhibit higher levels of chronic stress and stress reactivity
than those without subjective distress.
The results indicate that prevalence rates of FGID ac-
cording to the Rome II criteria were high in our sample,
with 62.78% of the subjects fulfilling at least one FGID
diagnosis. This is comparable to population-based studies
[1,30,31]. Studies which examined student samples found
comparable prevalence rates [24] or slightly lower rates
(51.2%) of FGID diagnoses [30]. Differences in prevalence
rates may be due to the use of different assessment instru-
ments for diagnosing FGID.
When a subjective distress criterion was considered,
the prevalence rates of FGID deviated considerably from
the original prevalence rates, with 38.6% of the sample
fulfilling the criteria for at least one diagnosis. On aver-
age, this constitutes a decrease of 38.51% across all FGID
and all participants. This decrease varies widely depend-
ing on the individual syndrome. In particular, the criteria
for aerophagia, chronic functional abdominal pain and
functional abdominal bloating were easily fulfilled, but
less than half of the affected participants reported sub-
jective distress elicited by the symptoms. Other FGID
showed only a slight decline in prevalence rates, which
may be attributable to the specific symptoms themselves
(e.g. functional chest pain could be interpreted as more
threatening than other symptoms) or to a possibly dif-
fering psychosocial relevance (e.g. the shame caused by
functional incontinence). Men showed more severe
drops in prevalence rates in 13 of the 21 syndromes. As
the case numbers for some FGID in this study were only
small, these findings need to be replicated in large
population studies.
Due to the great impact that the consideration of sub-
jective distress exerts on FGID prevalence rates, it might
be important to incorporate a subjective distress criterion
into the future Rome criteria, similar to the psychiatric
diagnostic criteria in the DSM-IV. Failing to consider the
distress criterion might potentially lead to an overesti-
mation of prevalence rates of FGID, because diagnoses are
only made based on positive symptom lists and exclusion
of physical illness, while neglecting to acknowledge the
degree of distress caused by the symptoms. It might be
speculated that the above-mentioned high prevalence
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rates of FGID in population-based and student samples
[1,24,30,31] indicate that the current FGID diagnostic
criteria are over-inclusive. A recently published study
recommended the consideration of multi-axial criteria
in the diagnosis of FGID [33]. Distress elicited by the
symptoms could be one of these criteria for measuring
the impact of the symptoms on the patient’s life.
In this non-clinical study, healthy subjects showed lower
values of chronic stress compared to subjects with at least
one FGID diagnosis, indicating a relationship between self-
reported gastrointestinal symptoms and work-related or
social stress. These findings are comparable to our previ-
ous results in another, independent sample of students
(Suarez et al., [24]). Importantly, however, subjects with at
least one FGID diagnosis who also reported that they were
subjectively distressed by their symptoms showed the high-
est values in each subscale of the Trier Inventory for the
Assessment of Chronic Stress, indicating high stress levels
during the past year. The positive association between
FGID (especially IBS) and chronic stress is well known.
Earlier studies found that groups with IBS showed greater
levels of daily stress compared to controls [17,34,35]. Our
study suggests that there is a relationship between the level
of chronic stress and the subjective distress caused by the
symptoms. Although the causal direction of this rela-
tionship remains unclear, it is conceivable that increased
chronic stress could exacerbate or facilitate the mainten-
ance of gastrointestinal symptoms which are subjectively
distressing. It is also possible, however, that perceived dis-
tress elicited by the symptoms may ultimately lead to
chronic stress in other areas of life. Studies with a longitu-
dinal design are needed to examine this causal relationship.
A similar pattern can be found regarding stress reactiv-
ity. Subjects with at least one self-reported FGID diagnosis
showed increased scores in each subscale of the Stress Re-
activity Scale. Again, this finding is in accordance with the
results of our previous study (Suarez et al., [24]), and the
results are in line with previous studies indicating in-
creased reactivity to stress in patients with IBS [21,22]. In
our current study, we found that stress reactivity was
highest in those individuals with FGID who also felt dis-
tressed by their symptoms, followed by non-distressed
subjects with FGID and healthy controls. While our data
indicate that there is a relationship between the level of
stress reactivity and subjective distress, due to the correl-
ational design of the study, the causal direction of this
relationship remains unclear. It is thus uncertain whether
increased stress reactivity leads to more distress due to
the symptoms or whether persons who are more dis-
tressed by their symptoms show a higher reactivity to
stress in other areas of life. Longitudinal designs are
needed to answer this question.
This study aimed to assess the impact of including a
subjective distress criterion in the diagnosis of FGID on
the prevalence rates of FGID. To the best of our know-
ledge, this aspect has not been previously examined.
Despite various advantages, some limitations need to be
taken into account when interpreting the study results:
The voluntary nature of participation may have led to a
self-selection bias, and as the subjects examined in the
sample did not undergo specific physical investigations,
a validation of the self-reported diagnoses is lacking.
Furthermore, the study should be repeated using the
current Rome III criteria in order to determine whether
our findings apply to these less conservative criteria as
well. However, the decrease in prevalence rates is likely
to be even larger in studies using the current Rome III
criteria due to the shorter symptom duration, meaning
that our results may be too conservative. We collected
data from a student sample, which cannot be considered
as representative of the general Swiss population regarding
e.g. age, level of education, socioeconomic status, and life-
style factors. Most population-based studies on FGID
included patients aged between 40 and 50 [12,36,37].
However, various studies have demonstrated that FGID
are also prevalent in younger individuals [24,38-40]. Thus,
while our findings are not representative of the majority of
potential FGID cases, our sample may provide important
insights into younger FGID patients.
We assume that biological, psychological, and social
aspects play a role in the development and maintenance
of FGID. Stress can cause a reduction in pain thresholds,
resulting in abdominal pain [41]. It can be assumed that
biomarkers related to stress, e.g. corticotropin-releasing
hormone (CRH), influence intestinal health and affect
intestinal motility in patients with functional gastrointes-
tinal syndromes [42]. Several studies [43-45] showed that
microbiota in IBS differ from microbiota in healthy con-
trols, and may therefore play an important role in the eti-
ology of IBS and other FGID. Future research is needed to
gain an understanding of the complex brain-gut interac-
tions, involving both endocrine pathways and intestinal
microbiota. With regard to our research focus, it would be
of great interest to ascertain whether subjects who fulfill
the distress criterion have different biological alterations
than those who do not.
Moreover, since cultural attitudes influence the open-
ness to report symptoms [46,47], these findings need to
be replicated in other cultural contexts.
Finally, we did not examine subjective beliefs, such as
catastrophizing or fear avoidance, in this study. Since
these psychological aspects are included in the new DSM-
5 criteria, they are becoming increasingly important. How-
ever, the psychological criteria are not independent of
each other and there is a lack of precise guidelines on how
to assess them [48]. For one specific FGID, i.e. irritable
bowel syndrome, the effect of catastrophizing on pain
severity and pain-related suffering is well documented
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[49-51]. Future studies should examine whether these psy-
chological aspects are related to the distress elicited by
one’s symptoms.
For the practitioner, we recommend simply asking pa-
tients which symptoms cause distress by using a 5-point
Likert scale from 0 (no distress) to 4 (very severe distress)
in the same way as it is done in the “Gastro-Question-
naire”, which was used in the current study and of which
an English version exists [25]. Persons who fulfill the
current Rome Criteria for an FGID and who grade the dis-
tress for at least one symptom as 2 or higher (moderate
distress) may then be classified as having an FGID diag-
nosis with distress. In addition, it would be desirable to
acquire information about chronic stress, e.g. using the
Screening Scale for Chronic Stress (SSCS) [26] which
consists of only 12 items.
Conclusion
The study revealed valuable information about the impact
of subjective distress on the prevalence rates of FGID. We
therefore suggest that a criterion of subjective distress
should be taken into consideration during the Rome IV
process. Moreover, our results might be important for
clinical practice because individuals who are distressed
by their symptoms are more likely to also present in-
creased stress levels. Stress management training could
be particularly beneficial for patients who report distress
due to their symptoms.
Additional files
Additional file 1: FGID diagnoses with and without subjective
distress for the complete sample and for each gender.
Additional file 2: Differences in chronic stress and stress reactivity
between the three subgroups.
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